ENDRA Life Sciences Inc. Quarterly Common Stock, Shares, Issued from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
ENDRA Life Sciences Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2016 to Q3 2024.
  • ENDRA Life Sciences Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 535K shares, a 93.6% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 535K -7.88M -93.6% Sep 30, 2024 10-Q/A 2024-11-21
Q2 2024 72.4M +65M +868% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 10.9M +7.75M +244% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 5.94K* -3.16M Dec 31, 2023 10-Q/A 2024-11-21
Q3 2023 8.41M -54.8M -86.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 7.48M -55.7M -88.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 3.17M -41.4M -92.9% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 3.17M +1.04M +48.9% Dec 31, 2022 10-K 2024-03-28
Q3 2022 63.2M +21M +49.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 63.2M +21.3M +50.9% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 44.6M +2.94M +7.08% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 2.13M -31.9M -93.8% Dec 31, 2021 10-K 2023-03-16
Q3 2021 42.2M +17.2M +68.6% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 41.9M +25.4M +155% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 41.6M +28.1M +207% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 34M +25.6M +304% Dec 31, 2020 10-K 2022-03-30
Q3 2020 25M +17.5M +233% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 16.4M +9.01M +121% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 13.6M +6.13M +82.6% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 8.42M +999K +13.5% Dec 31, 2019 10-K 2021-03-25
Q3 2019 7.52M +3.57M +90.4% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 7.42M +3.5M +89.2% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 7.42M +3.5M +89.2% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 7.42M +3.5M +89.2% Dec 31, 2018 10-K 2020-03-26
Q3 2018 3.95M +40.8K +1.04% Sep 30, 2018 10-Q 2018-11-05
Q2 2018 3.92M +16K +0.41% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 3.92M +3.2M +442% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 3.92M +3.2M +442% Dec 31, 2017 10-K 2019-03-11
Q3 2017 3.91M Sep 30, 2017 10-Q 2017-11-14
Q2 2017 3.91M Jun 30, 2017 10-Q 2017-08-07
Q1 2017 723K Mar 31, 2017 10-Q 2017-06-21
Q4 2016 723K Dec 31, 2016 10-K 2018-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.